Neuronetics, Inc. (STIM)

USD 1.37

(5.38%)

Total Debt Summary of Neuronetics, Inc.

  • Neuronetics, Inc.'s latest annual total debt in 2023 was 62.47 Million USD , up 57.19% from previous year.
  • Neuronetics, Inc.'s latest quarterly total debt in 2024 Q2 was 62.62 Million USD , up 0.24% from previous quarter.
  • Neuronetics, Inc. reported annual total debt of 39.74 Million USD in 2022, up 0.51% from previous year.
  • Neuronetics, Inc. reported annual total debt of 39.54 Million USD in 2021, up 3.15% from previous year.
  • Neuronetics, Inc. reported quarterly total debt of 62.62 Million USD for 2024 Q2, up 0.24% from previous quarter.
  • Neuronetics, Inc. reported quarterly total debt of 40.19 Million USD for 2023 Q3, down -0.03% from previous quarter.

Annual Total Debt Chart of Neuronetics, Inc. (2023 - 2016)

Historical Annual Total Debt of Neuronetics, Inc. (2023 - 2016)

Year Total Debt Total Debt Growth
2023 62.47 Million USD 57.19%
2022 39.74 Million USD 0.51%
2021 39.54 Million USD 3.15%
2020 38.33 Million USD 11.68%
2019 34.32 Million USD 12.93%
2018 30.39 Million USD 2.84%
2017 29.55 Million USD 46.77%
2016 20.13 Million USD 0.0%

Peer Total Debt Comparison of Neuronetics, Inc.

Name Total Debt Total Debt Difference
Bionano Genomics, Inc. 87.94 Million USD 28.964%
Prenetics Global Limited 2.36 Million USD -2536.715%
Star Equity Holdings, Inc. 3.6 Million USD -1631.061%
CareDx, Inc 34.22 Million USD -82.56%
Exact Sciences Corporation 2.55 Billion USD 97.555%
Exagen Inc. 23.72 Million USD -163.37%
Inotiv, Inc. 417.64 Million USD 85.041%
Guardant Health, Inc. 1.35 Billion USD 95.385%
Biodesix, Inc. 60.69 Million USD -2.938%
BioNexus Gene Lab Corp. 133.39 Thousand USD -46733.839%
Precipio, Inc. 1.11 Million USD -5498.029%
iSpecimen Inc. 196.24 Thousand USD -31734.859%
Natera, Inc. 441.99 Million USD 85.865%
Aspira Women's Health Inc. 2.26 Million USD -2657.017%
Standard BioTools Inc. 98.21 Million USD 36.387%
23andMe Holding Co. 76.51 Million USD 18.351%
Castle Biosciences, Inc. 15.31 Million USD -308.06%
Personalis, Inc. 48.96 Million USD -27.597%
Aclaris Therapeutics, Inc. 426 Thousand USD -14565.258%
Applied DNA Sciences, Inc. 1.23 Million USD -4947.344%
OpGen, Inc. 13.04 Million USD -378.959%
T2 Biosystems, Inc. 49.49 Million USD -26.215%
Myriad Genetics, Inc. 145 Million USD 56.914%
ICON Public Limited Company 3.93 Billion USD 98.414%
NeoGenomics, Inc. 611.67 Million USD 89.786%
Star Equity Holdings, Inc. 3.6 Million USD -1631.061%
IDEXX Laboratories, Inc. 947.88 Million USD 93.409%
RadNet, Inc. 1.49 Billion USD 95.81%
MDxHealth SA 41.26 Million USD -51.397%
Psychemedics Corporation 2.29 Million USD -2618.625%
Illumina, Inc. 2.26 Billion USD 97.238%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 94.06 Million USD 33.587%
DarioHealth Corp. 29.54 Million USD -111.482%
Fulgent Genetics, Inc. 14.9 Million USD -319.092%
Sera Prognostics, Inc. 1.85 Million USD -3262.433%
ENDRA Life Sciences Inc. 394.4 Thousand USD -15740.143%
OPKO Health, Inc. 326.56 Million USD 80.869%
Medpace Holdings, Inc. 142.12 Million USD 56.042%
Neogen Corporation 906.23 Million USD 93.106%
Intelligent Bio Solutions Inc. 871.44 Thousand USD -7069.054%
Prenetics Global Limited 2.36 Million USD -2536.715%
Mainz Biomed B.V. 7.42 Million USD -741.879%
bioAffinity Technologies, Inc. 1.57 Million USD -3857.46%
Trinity Biotech plc 67.42 Million USD 7.346%
Sotera Health Company 2.32 Billion USD 97.315%
bioAffinity Technologies, Inc. 1.57 Million USD -3857.46%